# Increased secreted PLA2 in epithelial cells promotes the progression of chronic non-atrophic gastritis to chronic atrophic gastritis through the TGF-β signaling

**Authors:** Hairong Hao, Yanjun An, Yuan Liu, Baole Li, Ran Zhang, Yingli Hao, Yuanyuan Pan, Na Li, Junfeng Kang

PMC · DOI: 10.1371/journal.pone.0343531 · PLOS One · 2026-03-04

## TL;DR

This study shows that secreted PLA2 promotes the progression of chronic gastritis through TGF-β signaling, offering a potential target for intervention.

## Contribution

Identifies PLA2G10 and TGF-β signaling as key drivers in the progression from CNAG to CAG.

## Key findings

- PLA2G10 inhibition reduces TGF-β expression and attenuates gastric mucosal inflammation.
- Blocking TGF-β signaling delays progression from CNAG to CAG, reducing inflammation and collagen deposition.

## Abstract

The progression of Chronic gastritis seems to follow a pattern from chronic non-atrophic gastritis (CNAG) to chronic atrophic gastritis (CAG) to cancer, so it is particularly important to block key targets in disease progression. A gene that synthesizes secreted phospholipase A2, attracted our attention.

To study whether phospholipase A2 group 10 (PLA2G10) in epithelial cells promote the progression of CNAG to CAG through the transforming growth factor-β (TGF-β) signaling.

We used RNA microarray and single-cell RNA sequencing datasets for bioinformatics analysis. The effects of PLA2G10 were verified by in vivo and in vitro experiments. The in vivo experiments used SD rats to establish a CNAG model for PLA2G10 and TGF-β intervention to observe the effects on gastric mucosal inflammation. In vitro experiments were conducted using human gastric mucosal epithelial cells (GES-1) for similar interventions.

PLA2G10 inhibition led to the downregulation of TGF-β expression and attenuated the inflammatory response of the gastric mucosa. And the blockade of TGF-β signalling delayed the progression of CNAG to CAG, as evidenced by a reduction in inflammatory cell infiltration, a more regular cellular arrangement, and a reduction in collagen deposition.

Our study shows that PLA2G10 plays a key role in the progression of chronic gastritis and highlights the important role played by the TGF-β signalling pathway in this process.

## Linked entities

- **Genes:** PLA2G10 (phospholipase A2 group X) [NCBI Gene 8399], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040]
- **Proteins:** TGFB1 (transforming growth factor beta 1)
- **Diseases:** chronic atrophic gastritis (MONDO:0006665)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** TMPRSS15 (transmembrane serine protease 15) [NCBI Gene 5651] {aka ENTK, PRSS7}, TGFBR2 (transforming growth factor beta receptor 2) [NCBI Gene 7048] {aka AAT3, FAA3, LDS1B, LDS2, LDS2B, MFS2}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Apob (apolipoprotein B) [NCBI Gene 238055] {aka Apo B-100, apob-100, apob-48}, Ace2 (angiotensin converting enzyme 2) [NCBI Gene 302668], TM4SF20 (transmembrane 4 L six family member 20) [NCBI Gene 79853] {aka PRO994, SLI5, TCCE518}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, Slc13a2 (solute carrier family 13 member 2) [NCBI Gene 65202] {aka Nadc1, mucin}, CYP4F2 (cytochrome P450 family 4 subfamily F member 2) [NCBI Gene 8529] {aka CPF2}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, CPA2 (carboxypeptidase A2) [NCBI Gene 1358], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 59086] {aka Tgfb}, TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113] {aka PRSS10}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}, PLA2G10 (phospholipase A2 group X) [NCBI Gene 8399] {aka GXPLA2, GXSPLA2, SPLA2, sPLA2-X}, BMP4 (bone morphogenetic protein 4) [NCBI Gene 652] {aka BMP2B, BMP2B1, MCOPS6, OFC11, ZYME}, LIPF (lipase F, gastric type) [NCBI Gene 8513] {aka GL, HGL, HLAL}, TPSAB1 (tryptase alpha/beta 1) [NCBI Gene 7177] {aka TPS1, TPS2, TPSB1, TPSB2, Tryptase-2}, Mttp (microsomal triglyceride transfer protein) [NCBI Gene 310900] {aka MTP}, Pla2g10 (phospholipase A2, group X) [NCBI Gene 29359] {aka PLA2GX, sPLA2-X}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, FABP2 (fatty acid binding protein 2) [NCBI Gene 2169] {aka FABPI, I-FABP}, CDH17 (cadherin 17) [NCBI Gene 1015] {aka CDH16, HPT-1, HPT1}, DMBT1 (deleted in malignant brain tumors 1) [NCBI Gene 1755] {aka GP340, SAG, SALSA, muclin}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD14 (CD14 molecule) [NCBI Gene 929], MTTP (microsomal triglyceride transfer protein) [NCBI Gene 4547] {aka ABL, MTP}, Fabp2 (fatty acid binding protein 2) [NCBI Gene 25598] {aka FABP}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, ATP4B (ATPase H+/K+ transporting subunit beta) [NCBI Gene 496] {aka ATP6B}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, MUC6 (mucin 6, oligomeric mucus/gel-forming (gene/pseudogene)) [NCBI Gene 4588] {aka MUC-6}, MUC5AC (mucin 5AC, oligomeric mucus/gel-forming) [NCBI Gene 4586] {aka MUC5, TBM, leB, mucin}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, TNFRSF11A (TNF receptor superfamily member 11a) [NCBI Gene 8792] {aka CD265, FEO, LOH18CR1, ODFR, OFE, OPTB7}, Mttp (microsomal triglyceride transfer protein) [NCBI Gene 17777] {aka 1810043K16Rik, MTP}, CHIA (chitinase acidic) [NCBI Gene 27159] {aka AMCASE, CHIT2, TSA1902}, ATP4A (ATPase H+/K+ transporting subunit alpha) [NCBI Gene 495] {aka ATP6A}, CD3D (CD3 delta subunit of T-cell receptor complex) [NCBI Gene 915] {aka CD3-DELTA, CD3DELTA, IMD19, T3D}, CHGA (chromogranin A) [NCBI Gene 1113] {aka CGA, PHE5, PHES}
- **Diseases:** fibrosis (MESH:D005355), CAG (MESH:D005757), Inflammatory (MESH:D007249), dysplasia (MESH:D015792), epigastric pain (MESH:D010146), Helicobacter pylori infection (MESH:D016481), cancer (MESH:D009369), atrophic (MESH:D020966), atrophy (MESH:D001284), intraepithelial neoplasia (MESH:D002578), autoimmune factors (MESH:D001327), gastric cancer (MESH:D013274), nausea (MESH:D009325), psoriasis (MESH:D011565), vomiting (MESH:D014839), gastric precancerous lesions (MESH:D011230), idiopathic pulmonary fibrosis (MESH:D054990), bile reflux (MESH:D001655), loss of appetite (MESH:D001068), pulmonary fibrosis (MESH:D011658), intestinal metaplasia (MESH:D007410), hyperplasia (MESH:D006965), UMAP (MESH:C567162), indigestion (MESH:D004415), CG (MESH:D005756)
- **Chemicals:** paraffin (MESH:D010232), carboxylic acid (MESH:D002264), pentobarbital sodium (MESH:D010424), triglyceride (MESH:D014280), phospholipids (MESH:D010743), TRIzol (MESH:C411644), free fatty acid (MESH:D005230), Alcian Blue (MESH:D000423), HE (MESH:D006371), DMEM (-), lipofectamine 2000 (MESH:C086724), fatty acids (MESH:D005227), CO2 (MESH:D002245), lipid (MESH:D008055), 1-Methyl-3-nitro-1-nitrosoguanidine (MESH:D008769), alcohol (MESH:D000438), Periodic Acid (MESH:D010504), DAPI (MESH:C007293), formalin (MESH:D005557)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PMC — Homo sapiens (Human), Finite cell line (CVCL_3773), GES-1 — Homo sapiens (Human), Transformed cell line (CVCL_EQ22)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12959716/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12959716/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12959716/full.md

---
Source: https://tomesphere.com/paper/PMC12959716